Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Electrostatic Dissipative Feature Augments New Line of Ductless Fume Hoods

By BiotechDaily International staff writers
Posted on 13 Aug 2013
Image: Aura ESD ductless fume hoods are self-contained, filtered enclosures that remove hazardous fumes, vapors and particles from virtually any laboratory application. Unlike traditional fume hoods, there are no installation costs and no ductwork is needed (Photo courtesy of Mystaire Misonix).
Image: Aura ESD ductless fume hoods are self-contained, filtered enclosures that remove hazardous fumes, vapors and particles from virtually any laboratory application. Unlike traditional fume hoods, there are no installation costs and no ductwork is needed (Photo courtesy of Mystaire Misonix).
Image: Aura - how it works: Laboratory air enters Aura at ″A″ and is combined with contaminated air at ″B″ before entering into filtration at ″C.″ Filtration at ″C″ can be gas phase, mechanical, or both depending on the application. At ″D,″ air is pulled into the plenum area. The gas detector and test port sampling tubing are located in this area. At ″E,″ optional safety filtration can be installed before contaminant-free air is returned to the laboratory space at ″F″ (Photo courtesy of Mystaire Misonix).
Image: Aura - how it works: Laboratory air enters Aura at ″A″ and is combined with contaminated air at ″B″ before entering into filtration at ″C.″ Filtration at ″C″ can be gas phase, mechanical, or both depending on the application. At ″D,″ air is pulled into the plenum area. The gas detector and test port sampling tubing are located in this area. At ″E,″ optional safety filtration can be installed before contaminant-free air is returned to the laboratory space at ″F″ (Photo courtesy of Mystaire Misonix).
A new line of fume hoods that promises laboratory workers superior protection against buildup of toxic fumes has been combined with electrostatic dissipative features to prevent static buildup and discharge.

Aura ductless fume hoods manufactured by Mystaire Misonix (Creedmoor, NC, USA) are self-contained, filtered enclosures that remove hazardous fumes, vapors, and particles from virtually any laboratory application. Unlike traditional fume hoods, there are no installation costs and no ductwork is needed. The new Aura ESD line of hoods adds an electrostatic dissipation feature to the state-of-the art Aura line.

Each Aura ductless fume hood has advanced safety monitoring and controls including the EverSafe II microprocessor safety controller, which monitors and adjusts fume hood face velocity to a user-preset value. EverSafe II maintains face velocity at the proper rate for containment of potentially toxic gases and vapors.

The US made Aura fume hoods, which are available in 72.6 centimeter, 106.68 centimeter, and 137.16-centimeter widths have been ASHRAE (American Society of Heating, Refrigerating and Air Conditioning Engineers) 110 tested and provide excellent containment from toxic fumes and vapors. The Filtrak positive filter sealing system installed in each Aura ductless hood is a cam-driven filter sealing system with a built-in filter position indicator and an alert that informs the user if the filtration bed is not properly sealed. The Filtrak system enables safe and easy filter maintenance and replacement.

Related Links:
Mystaire Misonix



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Illustration of the apoER2 receptor protein shows the structure of the entire protein in detail (Photo courtesy of Wikimedia Commons).

Risk of Cardiovascular Disease Linked to Apolipoprotein E Variants

The apoE4 variant form of circulating apolipoprotein E (apoE) leads to increased risk of cardiovascular disease by blocking binding of the normal apoE3 form to the apoliprotein E receptor 2 (apoER2) in... Read more

Drug Discovery

view channel
Image: S-649266 has more robust antibacterial activity than established antibiotics against multidrug-resistant bacteria (Photo courtesy of Shionogi).

Novel Antibiotic Shows Potential for Broad Range of Infections

The emergence of bacterial resistance to known antibacterial agents is becoming a major challenge in treating the infection caused by multi drug resistant (MDR) bacteria. In order to treat bacterial... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.